AVROBIO stockholders approve all proposals for merger with Tectonic Therapeutic

Tectonic Therapeutic, Inc.

Stock issuance and change-of-control proposal passed: 30,233,557 For, 1,899,576 Against.
Reverse stock split (1:3 to 1:30 range) approved: 29,802,382 For, 2,181,632 Against.
Tectonic 2024 Equity Incentive Plan approved: 25,325,215 For, 6,747,913 Against.
Advisory vote on M&A executive compensation approved: 29,551,916 For, 2,530,022 Against.
Adjournment proposal approved but not needed as stock issuance and reverse split passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.